Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I would say it’s because of our greedy BOD. Who have no negotiating skills what so ever. I don’t think it’s the science but could be wrong.
Can we get some god damn news already!!!!!
I hear you but unfortunately wasn’t it the BOD that approved what Tony L made for doing absolutely nothing for a year. I would worry more that we have what seems to be one of the worst BOD’s in the industry. Hopefully the science will be strong enough to save us.
“then they hired someone who just lead their company into bankruptcy.”
Unfortunately I don’t agree with your statement. I would recommend you go read and and educate yourself on how some of the richest people in the world all failed at first and some more then once. I’m okay with Kenny B not having the best track record before being hired but we can only hope that he also learned from his mistakes and can use them to turn this company around. It definitely will not be an easy job but I do believe he will get help as results from NEO start to show.
It’s funny how many times I see Tony Lombardo mentioned on this MB as a failure. If you look at the timing of when he was hired and his position. You can tell that he was brought on so they could remove Dan O’Conner. It seems like he was only going to remain CEO until they found a replacement. Which unfortunately took longer then they expected or didn’t go the way they thought but please don’t kid yourself. Tony L. was never meant to run this company long term but was definitely paid well for his time spent. The BOD and Robert Petit are running this company and hopefully good things are to come
So far Ken seems like a straight shooter. I think he is definitely trying to steer this ship in the right direction! Time is definitely against him but I know Petit was very excited about NEO years ago. If the money we have can hold us out long enough. I think we will see outstanding results!!!
The announcement of the ADXS and BMY combo trial was a joke from the beginning. It was never going to happen unless BMY was paying the bill because we sure as hell didn’t have the money.
Maybe this will help. Stendhal was to give 10 million towards trial cost. I do remember seeing ONE payment of 3 million and I believe that was a couple years ago. I have not seen any more payments reported. Has anybody else??
The start of the NEO trial should have triggered a milestone payment but seeing how Danny boy negotiated this deal. I wouldn’t be surprised if there was not one but he sure didn’t forget to award himself 150,000 shares for completing the NEO IND. What a crook!!!!
Hovacre, did the 30 day wash rule come into play with your sale and repurchase
From today’s PR
“The Company plans to initiate a Phase 1/2 clinical trial that will seek to establish the safety, tolerability and effectiveness of ADXS-503 administered alone and in COMBINATION WITH A CHECKPOINT INHIBITOR in approximately 50 patients with metastatic NSCLC in different lines of therapy, at up to 20 centers across the U.S.”
Just wondering? Who’s checkpoint inhibitor do they have mind? I can only hope that this time we aren’t paying the bill for the combo part of the trial. I’m going to take a guess and say Merck will finally become a real partner with some upfront cash for these trials.
Nice to see that IND application went fast and smooth. NEO and HOT are going to be huge!!!
Come on Kenny, I know you’re a late in the week PR kind of guy. Give us what we want. I can’t see how Merck isn’t going to be the one to make a deal for HOT-Prostate.
Just like I said last week. If you have some extra money add at these ridiculous levels. Deal is coming for HOT soon. Which I believe returns us to about $12 pps.
I believe a deal for HOT is basically done. If you have any extra money. Now would be the time to buy at this ridiculous pps
I personally don’t see BMY as one of our partners and I believe AXAL is out dated already. Hoping someone like AZN takes AXAL off our hands but I don’t think we will get to much at this point. Just my opinion
They are in talks with Amgen for NSCLC - HOT and Prostate-HOT with Merck. Just my opinion, glta
We know Kenny boy likes to release good news on Friday. So here’s to hoping he has something for tomorrow. If not it won’t be long until we have a deal in place for our HOT program.
Maybe it’s the only place that would take her
lol, OncoSec Appoints Sara M. Bonstein as Chief Financial Officer and Chief Operating Officer
It would be nice to see it climb back up little before end of day
Ken seems to like to release good news on Fridays. I like this guy!!! Let’s go Advaxis baby
I can’t believe we are sitting at this pps. They have ruined this company!! Hopefully they have a plan to bring it back from the dead
Your new CEO is a criminal!!!!! Be prepared to be bent over!!!
Yes I do believe you are right that Merck could be the lead partner for Prostate HOT but the ongoing PSA trial I believe will come to an end
AXAL is done and PSA is next. That is why they are targeting Prostate for the next HOT IND. I added shares recently only because I knew NEO was getting ready to start. NEO and HOT are this companies last chance and we should know by end of year if NEO is working and how much interest there really is in HOT. So within the next 6 months there should be no reason a deal is not struck if HOT is everything they say it’s cracked up to be. I do believe NEO and HOT will deliver but the only thing you can do now is hope and pray or a lot of investors are going to lose a lot of money. Myself included, glta
god only knows how many millions of dollars and resources were wasted for that EU filing
Oh boy not good but kind of saw that coming. Can’t wait to hear the cheerleaders excuses today!
Who’s to say other employees aren’t heading for the doors and now they are trying to fill those positions
It was an additional 5000 and 9000 shares for about $25,000 out of pocket
I believe the 6/29 purchase is the monthly purchase. So the answer is yes
Going off memory!! I believe Global BioPharma was supposed to have been responsible for up to 150 patients of a phase 3 trial. Most of the deals are so old it’s hard to remember but the big questions are we getting anything from any of those old deals as of today
I don’t think they can terminate the trial either but they can probably stop enrolling. We need to look at the financials because I’m not sure we ever received more than the 3 of the 10 million so far from Stendhal
I do remember that being said but that was also Dan O’Connor speaking. So there goes that. I could be way off but a trial this size for X amount of years. Has to be costly
I don’t think Stendhal is paying most of the cost for the phase 3. They were contributing 10 million. Wouldn’t a phase 3 this size cost upwards of 30 million? Also I only remember Advaxis reporting one payment from them. Which was around 3 million but I could be wrong
Yeah I’m sure that is what Adage does with their time. OMG, LOL
Do you even know what you’re doing besides brown nosing other investors that only pump and make you drink the cool aid. Drink up boy
WOW more free shares for the BOD’s that are doing just a bang up job! They should be a shamed to take those shares
Ok but the month isn’t over. So he at least deserves that. Maybe we see something end of day, tomorrow or Friday
Please don’t go there because that is one of my big fears now that the pps continues to drop. We need a deal for HOT program or unload AXAL for some money. If anyone still wants it